Key facts
- Notable investors include TusStar Incubator, Fan Zhuo Capital, Shenzhen Lihe Science and Technology Innovation.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Beichen Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Beichen Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Beichen Biotechnology
Provider of biotechnology research services designed for diagnostic and analytical purposes. The company offers detection systems, biochemical assay development, laboratory instrumentation, reagent preparation, and supporting technical services, enabling healthcare, pharmaceutical, and research markets to strengthen diagnostic accuracy, expand application in clinical and laboratory environments, improve reliability of testing workflows, enhance scalability of analytical processes, and support localized innovation capacity through structured research, production, and service integration.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2021
- Ownership
- Privately Held (backing)
Beichen Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Beichen Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Beichen Biotechnology in its N-PORT filings yet. We sweep new filings monthly.